Scarica l'app Stockscreener
2.92
3.18%
0.09
Pre-mercato:
2.98
0.06
+2.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$2.83
Aprire:
$2.83
Volume 24 ore:
7.63M
Relative Volume:
2.02
Capitalizzazione di mercato:
$656.37M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-1.9864
EPS:
-1.47
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
+0.69%
1M Prestazione:
+32.73%
6M Prestazione:
+76.97%
1 anno Prestazione:
-45.42%
Intervallo 1D:
$2.81
$3.07
Intervallo di 1 settimana:
$2.60
$3.07
Portata 52W:
$1.26
$7.40
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
2.92 | 656.37M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
SANA Stock on the Rise: A Promising Investment - investchronicle.com
Investigation announced for long-term Investors in shares - openPR.com
Pallas Capital Advisors LLC Makes New $29,000 Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology (NASDAQ:SANA) versus Mosaic ImmunoEngineering (OTCMKTS:CPMV) Critical Analysis - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 25,383 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Lead Plaintiff Appointed in Sana Biotechnology Class Action — Here’s How You Can Recover Your Losses - TradingView
Paysign Leads Our Trio Of Penny Stock Highlights - simplywall.st
Transcript : Sana Biotechnology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Sana Biotechnology to present at 85th annual American Diabetes Association Scientific Sessions - marketscreener.com
Sana Biotechnology to Present First-in-Human Clinical Data on Hypoimmune Islet Cell Therapy for Type 1 Diabetes at ADA Scientific Sessions - Nasdaq
Sana Biotechnology Announces Invited Oral Presentation at - GlobeNewswire
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes ... - Bluefield Daily Telegraph
Sana Bio to Present Novel Immunosuppression-Free Diabetes Cell Therapy Data at ADA | SANA Stock News - Stock Titan
Shareholders Filed a Lawsuit Against $SANA for Misleading Investors About Financial Health - TradingView
Two Sigma Investments LP Grows Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Ameriprise Financial Inc. Invests $29,000 in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Squarepoint Ops LLC Buys 55,625 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Elects Directors at Annual Meeting - TipRanks
Transcript : Sana Biotechnology, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 02 - MarketScreener
Sana Biotechnology, Inc. (NASDAQ:SANA) Stock Position Raised by Two Sigma Advisers LP - Defense World
Nuveen Asset Management LLC Sells 27,104 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Biggest Stocks in NASDAQ Featuring Sana Biotechnology and Kalkine - Kalkine Media
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Millennium Management LLC - Defense World
BNP Paribas Financial Markets Makes New Investment in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Bank of America Corp DE Increases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
ProShare Advisors LLC Grows Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Rosen, Pomerantz To Lead Seattle Biotech Class Action - Law360
Are Investors Declined To Sell Their Sana Biotechnology Inc (NASDAQ: SANA) Holdings? - Stocksregister
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Deutsche Bank AG Sells 72,413 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Reveals Latest Cell Therapy Progress at Jefferies and Goldman Sachs Healthcare Conferences - Stock Titan
Sana Biotechnology to Present at June 2025 Investor Conferences - GlobeNewswire
Jane Street Group LLC Boosts Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Sana Biotechnology’s SWOT analysis: engineered cell stock faces pivotal year By Investing.com - Investing.com South Africa
Northern Trust Corp Buys 60,004 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology’s SWOT analysis: engineered cell stock faces pivotal year - Investing.com Nigeria
Focus Partners Wealth Takes Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Securities Lawsuit Alert: Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - The Malaysian Reserve
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Contact Levi & Korsinsky by May 20, 2025 to Join Class Action Against Sana Biotechnology, Inc. (SANA) - ACCESS Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment - Seeking Alpha
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, ... - Eagle-Tribune
SANA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
The End Of The Diabetes Industry?Eli Lilly (NYSE:LLY), DexCom (NASDAQ:DXCM) - Benzinga
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Sana Biotechnology, Inc. (SANA) Investors of May 20, 2025 Deadline - ACCESS Newswire
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sana Biotechnology Inc Azioni (SANA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):